Back

Decisive role of microRNA-494 in smooth muscle cell proliferation and vascular remodeling

31 August 2019 (11:12 - 11:25)
Organised by:
Congress Presentation Part of: Non-coding RNAs in cardiovascular disease Genetics, Epigenetics, ncRNA ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Kai Knoepp

University Hospital Halle (Saale), Halle (Germany)

6 More presentations in this session

Presentation thumbnail
Identification of differential roles of microRNA-33a and -33b during atherosclerosis progression with genetically modified mice
Doctor T. Horie (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Circulating muscle-derived mir-206 links skeletal muscle dysfunction to cardiac autonomic denervation
Doctor T. Zaglia (Padova, IT)
Abstract
Presentation thumbnail
Through differential targeting of cardiac myocytes and fibroblasts, miR-221 promotes myocardial recovery and averts adverse remodeling after infarction
Doctor Y. Zhou (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
The long noncoding RNA H19 modulates cardiac remodeling after infarction
Miss O. CHOONG (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Amyloid beta 1-40 and its upstream regulatory pathway BACE1-AS long noncoding RNA /BACE1 are associated with presence and severity of human atherosclerotic disease
Doctor M. Sachse (Hamburg, DE)
Abstract

Access the full session

Session thumbnail
Non-coding RNAs in cardiovascular disease

The Event

Event poster

ESC Congress 2019

31 August 2019 11:12 CET
You may be interested in
thumbnail
Congress Presentation
Tissue microRNA expression in aortic aneurysm dissection
27 August 2021
thumbnail
Congress Presentation
The dihydropyridine calcium antagonist nicardipine reduces aortic smooth muscle cell viability, proliferation and migration
20 April 2018
thumbnail
Congress Presentation
Exploring the interactions between cardiomyocytes and endothelial cells to induce cardiac revascularization and regeneration
12 April 2024
thumbnail
Congress Presentation
Role of S100A4 in atherosclerosis development
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources